SEC Form 4 · accession 0001214659-15-000048
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Debra Odink
Officer — Chief Technology Officer
Period of report
Dec 30, 2014
Accepted (ET)
Jan 2, 2015 · 6:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 30, 2014 | G | 1,364 | $0.00 | D | 9,101 | D | |
| Common Stock | Dec 30, 2014 | G | 1,364 | $0.00 | A | 13,855 | I | By The Debra A. Odink Living Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2 | $1.61 | Dec 30, 2014 | A | 120,000 | A | — | Dec 30, 2024 | Common Stock | 120,000 | 120,000 | D |
Explanation of responses
- F1On December 31, 2014, the Reporting Person transferred 1,364 shares to the Debra A. Odink Living Trust.
- F2This stock option vests monthly over four years beginning December 30, 2014 (the Vesting Start Date). The Stock Option is completely vested on the fourth anniversary of the vesting start and will expire on December 30, 2024.